BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37083309)

  • 1. Glutathione and Esterase Dual-Responsive Smart Nano-drug Delivery System Capable of Breaking the Redox Balance for Enhanced Tumor Therapy.
    Shen P; Zhang X; Ding N; Zhou Y; Wu C; Xing C; Zeng L; Du L; Yuan J; Kang Y
    ACS Appl Mater Interfaces; 2023 May; 15(17):20697-20711. PubMed ID: 37083309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy.
    Zhang L; Zhang S; Li M; Li Y; Xiong H; Jiang D; Li L; Huang H; Kang Y; Pang J
    Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111956. PubMed ID: 33812584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile synthesis of poly(disulfide)s through one-step oxidation polymerization for redox-responsive drug delivery.
    Zhang R; Nie T; Wang L; He D; Kang Y; Zhang C; Wu J
    Biomater Sci; 2023 Jun; 11(12):4254-4264. PubMed ID: 37144301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer.
    Tian X; Bera H; Guo X; Xu R; Sun J; He Z; Cun D; Yang M
    ACS Appl Mater Interfaces; 2021 Dec; 13(48):56858-56872. PubMed ID: 34806372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active targeting redox-responsive mannosylated prodrug nanocolloids promote tumor recognition and cell internalization for enhanced colon cancer chemotherapy.
    Gao Y; Qiu W; Liang M; Ma X; Ye M; Xue P; Kang Y; Deng J; Xu Z
    Acta Biomater; 2022 Jul; 147():299-313. PubMed ID: 35640802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor pH(e)-triggered charge-reversal and redox-responsive nanoparticles for docetaxel delivery in hepatocellular carcinoma treatment.
    Chen F; Zhang J; Wang L; Wang Y; Chen M
    Nanoscale; 2015 Oct; 7(38):15763-79. PubMed ID: 26355843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
    Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
    Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione and Reactive Oxygen Species Dual-Responsive Block Copolymer Prodrugs for Boosting Tumor Site-Specific Drug Release and Enhanced Antitumor Efficacy.
    Yin W; Ke W; Lu N; Wang Y; Japir AAMM; Mohammed F; Wang Y; Pan Y; Ge Z
    Biomacromolecules; 2020 Feb; 21(2):921-929. PubMed ID: 31961134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
    Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin-based supramolecular nanoparticles break the redox balance in chemodynamic therapy-enhanced chemotherapy.
    Xing C; Chen H; Guan Y; Zhang S; Tong T; Ding N; Luo T; Kang Y; Pang J
    J Colloid Interface Sci; 2022 Dec; 628(Pt B):864-876. PubMed ID: 36029600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart dual responsive nanocarriers with reactive oxygen species amplification assisted synergistic chemotherapy against prostate cancer.
    Guan Y; Xing C; Tong T; Zhang X; Li J; Chen H; Zhu J; Kang Y; Pang J
    J Colloid Interface Sci; 2022 Sep; 622():789-803. PubMed ID: 35544966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
    Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
    Li Y; Chen X; Ji J; Li L; Zhai G
    Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
    Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
    Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer.
    Zhu G; Wang K; Qin H; Zhao X; Chen W; Xu L; Cao W; Guo H
    J Nanobiotechnology; 2020 Sep; 18(1):124. PubMed ID: 32887622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer.
    Chen Y; Xu Z; Lu T; Luo J; Xue H
    Drug Deliv; 2022 Dec; 29(1):2705-2712. PubMed ID: 35980107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Redox-Activatable and Targeted Photosensitizing Agent to Deliver Doxorubicin for Combining Chemotherapy and Photodynamic Therapy.
    Yin J; Ouyang C; Shen S; Zhou Y; He G; Zhang H; Zhou K; Chen G; Ren L
    Mol Pharm; 2022 Jul; 19(7):2441-2455. PubMed ID: 35616274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
    Kou L; Sun R; Xiao S; Zheng Y; Chen Z; Cai A; Zheng H; Yao Q; Ganapathy V; Chen R
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26722-26730. PubMed ID: 31276364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Manganese doped silica nano GSH-cleaner for treatment of Liver Cancer by destroying the intracellular redox homeostasis.
    Tang H; Li C; Zhang Y; Zheng H; Cheng Y; Zhu J; Chen X; Zhu Z; Piao JG; Li F
    Theranostics; 2020; 10(21):9865-9887. PubMed ID: 32863964
    [No Abstract]   [Full Text] [Related]  

  • 20. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
    Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
    J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.